Alison J. Hardcastle mainly investigates Genetics, Retinitis pigmentosa, Mutation, Cell biology and Retinal degeneration. Her Gene mapping, Exon, Gene and Primer walking study, which is part of a larger body of work in Genetics, is frequently linked to Eye disorder, bridging the gap between disciplines. Her Gene mapping research is multidisciplinary, incorporating perspectives in UniGene, Expressed sequence tag, Human genome and Pseudogene.
Alison J. Hardcastle has included themes like Positional cloning, Genetic heterogeneity and Nonsense mutation in her Retinitis pigmentosa study. Her Cell biology research is multidisciplinary, incorporating perspectives in Retinal pigment epithelium and Photoreceptor Connecting Cilium. Her biological study deals with issues like Rhodopsin, which deal with fields such as Color Vision Defects and Monochromacy.
Her scientific interests lie mostly in Genetics, Gene, Retinitis pigmentosa, Retinal degeneration and Exon. Genetics is represented through her Locus, Mutation, Gene mapping, Genetic linkage and Candidate gene research. She has included themes like Positional cloning, Rhodopsin, Genetic heterogeneity and Frameshift mutation in her Retinitis pigmentosa study.
The Retinal degeneration study combines topics in areas such as Nonsense mutation, Electroretinography and Cell biology. Her work deals with themes such as Missense mutation, Molecular biology and Opsin, OPN1MW, OPN1LW, which intersect with Exon. While the research belongs to areas of Missense mutation, she spends her time largely on the problem of Corneal dystrophy, intersecting her research to questions surrounding Pathology.
Alison J. Hardcastle spends much of her time researching Genetics, Retinal, Posterior polymorphous corneal dystrophy, Molecular biology and Keratoconus. Her study in Genetics focuses on RNA splicing, Exome sequencing, Sanger sequencing, Genome wide analysis and Mendelian Randomization Analysis. Alison J. Hardcastle studies Retinitis pigmentosa, a branch of Retinal.
Her studies deal with areas such as Animal model, Optometry, Translational medicine and Cell biology as well as Retinitis pigmentosa. Posterior polymorphous corneal dystrophy is a subfield of Gene that Alison J. Hardcastle investigates. Alison J. Hardcastle focuses mostly in the field of Molecular biology, narrowing it down to topics relating to Opsin and, in certain cases, Photopigment and Optical coherence tomography.
Her primary scientific interests are in Molecular biology, Haploinsufficiency, Corneal dystrophy, Gene and Retinal. Her Molecular biology study frequently involves adjacent topics like Optical coherence tomography. Her Haploinsufficiency study incorporates themes from Corneal endothelium, Transcription factor, Posterior polymorphous corneal dystrophy, HEK 293 cells and Ectopic expression.
Her biological study spans a wide range of topics, including MBNL1, Corneal transplantation, Cancer research and Trinucleotide repeat expansion. Alison J. Hardcastle combines topics linked to Hearing loss with her work on Gene. Her study ties her expertise on Exon together with the subject of Retinal.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein
Carsten M. Pusch;Christina Zeitz;Oliver Brandau;Katrin Pesch.
Nature Genetics (2000)
The cone dysfunction syndromes
Jonathan Aboshiha;Adam M Dubis;Joseph Carroll;Alison J Hardcastle.
British Journal of Ophthalmology (2004)
The pathogenesis of keratoconus
A. E. Davidson;Sally Hayes;A. J. Hardcastle;S. J. Tuft.
Eye (2014)
Progressive cone and cone-rod dystrophies: Phenotypes and underlying molecular genetic basis
Michel Michaelides;Michel Michaelides;Alison J. Hardcastle;David M. Hunt;Anthony T. Moore;Anthony T. Moore.
Survey of Ophthalmology (2006)
Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups.
David A. Parfitt;Amelia Lane;Conor M. Ramsden;Conor M. Ramsden;Amanda Jayne F Carr.
Cell Stem Cell (2016)
Unfolding retinal dystrophies: a role for molecular chaperones?
J.Paul Chapple;Celene Grayson;Alison J. Hardcastle;Richard S. Saliba.
Trends in Molecular Medicine (2001)
Localization in the human retina of the X-linked retinitis pigmentosa protein RP2, its homologue cofactor C and the RP2 interacting protein Arl3
Celene Grayson;Francesca Bartolini;J. Paul Chapple;Keith R. Willison.
Human Molecular Genetics (2002)
The retinitis pigmentosa protein RP2 links pericentriolar vesicle transport between the Golgi and the primary cilium
R. Jane Evans;Nele Schwarz;Kerstin Nagel-Wolfrum;Uwe Wolfrum.
Human Molecular Genetics (2010)
Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23)
Tom R. Webb;David A. Parfitt;Jessica C. Gardner;Ariadna Martinez.
Human Molecular Genetics (2012)
Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study.
Alison J. Hardcastle;Dawn L. Thiselton;Lionel Van Maldergem;Bratin K. Saha.
American Journal of Human Genetics (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University College London
University of California, San Francisco
University College London
Moorfields Eye Hospital NHS Foundation Trust
University College London
King's College London
University of Leeds
Imperial College London
University of Cambridge
University of California, Los Angeles
University of Bristol
Agency for Science, Technology and Research
University of Notre Dame
The Ohio State University
Albert Einstein College of Medicine
King Abdullah University of Science and Technology
University of Natural Resources and Life Sciences
Tokyo University of Agriculture and Technology
Temple University
University of Toronto
Harvard University
Centers for Disease Control and Prevention
Dalhousie University
University of Tokyo
National Cancer Center
University of Barcelona